SAN DIEGO, January 5, 2012 — Today, Jacob Tyler, a nationally-acclaimed, full-service brand communications agencybased in San Diego, announced it would serve as the agency of record for Aviir, a biotechnology company that has revolutionized cardiovascular diagnostic testing. As agency of record, Jacob Tyler will be developing a full rebrand of Aviir which will include corporate identity design, creative campaigns, interactive collateral, social media, and ongoing public relations.
“We thrive on our ability to accept a challenge and love the idea of marketing such a great tested product that has the potential to save lives,” said Les Kollegian, CEO of Jacob Tyler. “Because of our experience in biotechnology, we have the understanding it takes to ‘move the needle’ when it comes to branding a company like Aviir; a key reason we feel we were chosen for the job over other agencies.”
“Aviir’s mission is to identify and prevent cardiovascular disease, and subsequent deaths, through proprietary blood tests and treatment plan recommendations,” said Douglas Harrington, M.D., Chief Executive Officer of Aviir. He added. “We have very lofty goals to increase our brand recognition among physicians and patients in 2012 and we feel confident in Jacob Tyler’s ability to deliver.
With this addition to its client base, Jacob Tyler adds yet another leading company to its growing list of national and international clients. The agency has more than tripled the size of its staff, clients and office space, since inception, to accommodate larger accounts and the influx of business.
About Jacob Tyler:
Jacob Tyler is a full-service brand communications agency that creates brands with meaningful and significant value. It does so through its expertise in brand strategy, identity and implementation, which includes web design and development, product design, printed collateral, online marketing, social media, and reputation management. It has been honored by Inc. 5000 as one of America’s fastest growing companies in 2010, was named by the San Diego Business Journal as one of the city’s fastest growing companies, five years in row, and has been the recipient of more than fifty national design and marketing awards. Clients served include Nuvasive Inc, Chicago’s Hotel 71, Four Seasons Hotels, Terranea Resort, AT&T, Rhino Vehicle Protection, Milwaukee Motorcycle Clothing and Upper Deck.
Aviir was founded in 2005 by cardiologists and scientists from the Stanford University School of Medicine to focus on discovery, development and commercialization of innovative diagnostic tests. The biotechnology company specializes in developing proprietary diagnostic tests that will assist in identifying patients that are truly at high risk for the development of a cardiac event. Aviir’s proprietary TruRisk™ assessments objectively identify, by a simple blood draw, individuals who are at a high risk of a cardiac event over the next five years. Aviir’s CLIA laboratory (Irvine, CA) complements these novel tests with a wide range of additional tests for risk assessment and therapeutic monitoring of cardiovascular disease and related metabolic disorders – including pharmacogenomic and other genetic tests. The company has adopted a unique clinical laboratory service model to provide physicians better diagnostic tools that improve cardiovascular health of their patients. The company is privately owned and funded by leading life science venture capital firms.